Business
Ventripoint Diagnostics Provides a Corporate Update
(TheNewswire) Toronto, Ontario – TheNewswire – March 16, 2023 - Ventripoi...
About this update from Ventripoint Diagnostics Ltd.
[{"type":"text","content":"Ventripoint Diagnostics Provides a Corporate Update\n \n \n (TheNewswire)\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Toronto, Ontario – TheNewswire –\nMarch 16, 2023\n \n \n - Ventripoint Diagnostics Ltd.\n(\"\n \n \n Ventripoint\n \n \n \" or the \"\n \n \n Company\n \n \n \"), (TSXV:VPT\n \n \n )\n \n \n ;\n \n \n (\n \n \n OTC:VPTDF) is pleased to provide a corporate update on the\nCompany’s current status and the outlook for 2023.\n \n \n \n \n The Company enters 2023 following an extensive period\nof innovation and refinement of its core technology and is now\nwell-positioned to capitalize on those investments in creating\nawareness and driving market adoption.\n \n \n \n \n Dr. Alvira Macanovic, Ventripoint’s President &\nCEO stated, “2022 was a transformative year for Ventripoint, and the\ncompany is in a much stronger position going forward.  Ventripoint\nhas gained traction in sales in its key markets and continues momentum\nas we pursue our mission to improve the lives of patients by providing\nbetter, simpler, and intelligent tools that give clinicians more\naccurate information and solve their immediate needs. My primary focus\nnow is to drive revenues as a result of the\n \n \n tactical\n \n \n growth in our salesforce,\nchannel partners and trial teams.”\n \n \n \n \n Sales, Marketing, and\nDistribution\n \n \n \n \n One of Ventripoint’s primary strategic goals for 2023\nis to accelerate sales growth.  The Company’s sales and marketing\nefforts continue to focus on the latest generation VMS+ product to\nleading hospitals and clinics worldwide.  Clinicians that have\nevaluated the technology see the potential for our products to elevate\nthe care they provide to their patients and are impressed at how well\nVentripoint products provide consistent, reliable, and accurate\nmeasurements, especially for their most complex cases.\n \n \n \n \n During 2022 Ventripoint investments in sales and\nmarketing infrastructure included:\n \n \n \n \n \n \n Key hires of strategic sales leaders to cover the\nUnited States, Europe, and the United Kingdom.\n \n \n \n \n \n \n Hires in clinical applications and technical support to\nsupport its sales team, including direct sales and\ndistributors.\n \n \n \n \n \n \n Partnerships with 11 di...